Prehabilitation for Kidney Transplant Candidates

The Methodist Hospital Research Institute (TMHRI)

Status: Enrolling

Conditions: Kidney Transplantation; Frailty; Chronic Kidney Insufficiency

Treatments: Device: Polar H10 Heart Rate Monitor; Device: Empatica EmbracePlus; Device: Apple Watch Ultra 2

Study type: Interventional

Funder types: Other

Identifiers

NCT06886256

PRO00038084

Details and patient eligibility

About

This interventional trial seeks to determine the feasibility of wearable sensors to provide data from patients while undergoing supervised exercise.

Full description

This pilot study is a prospective, non-randomized, interventional trial of measures of prehabilitation in kidney transplant candidates who are frail. Kidney transplant candidates who meet criteria for the study will have wearable sensors placed for monitoring during the exercise session of their prehabilitation. The sensors will capture data during the single exercise session and transfer the data to a mobile health (mHealth) platform. The study aims to use the information from the sensors to develop future studies where the exercise is adjusted based on the sensor reports.

Enrollment: 15 estimated patients

Sex: All

Ages: 55+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Adult Frail patients who are being evaluated for kidney transplant at Houston Methodist Hospital
2. Male or Female, aged 55 or older
3. Provision of signed and dated informed consent by the participant
4. Willingness to comply with study procedures and the duration of the study

Exclusion criteria

1. Inability or contraindication to exercise
2. Refusal to participate
3. Inability to consent or effectively communicate

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

15 participants in 1 patient group

Intervention

Experimental group

Description:

Each participant will have 3 wearable sensors placed during a single exercise event. The data collected from the sensors will be transferred to a mHealth platform for monitoring feasibility.

Treatment:

Device: Apple Watch Ultra 2

Device: Empatica EmbracePlus

Device: Polar H10 Heart Rate Monitor